N-Nitroso-Betaxolol
✓
データの正確性100%
24時間年中無休の科学サポート
⬡
品質に対する妥協ゼロ

在庫拠点

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* 在庫状況によります

Documentation

MSDSをダウンロード

サンプルCOAをダウンロード

内容: HPLC、MASS/LC-MS、1H NMR、FT-IR、含量、構造解析レポート(SER)、および製品に応じた追加分析データ。

N-Nitroso-Betaxolol

● 在庫あり

カタログ番号:VE0012730
CAS番号:N/A
分子式:C18H28N2O4
分子量:336.43 g/mol

に関する追加情報 N-Nitroso-Betaxolol

FDA Potency Category 4 NDSRI

1500 ng/day is the U.S. FDA’s current Acceptable Intake (AI) limit for N-nitroso-betaxolol (NDSRI). Refer to the FDA nitrosamine page for the latest guidance.

親薬物

Betaxolol

IUPAC名

N-(3-(4-(2-(cyclopropylmethoxy)ethyl)phenoxy)-2-hydroxypropyl)-N-isopropylnitrous amide

薬局方同義語

N/A

Other Synonyms

N/A

SMILES

O=NN(CC(O)COC1=CC=C(CCOCC2CC2)C=C1)C(C)C

InChl

InChI=1S/C18H28N2O4/c1-14(2)20(19-22)11-17(21)13-24-18-7-5-15(6-8-18)9-10-23-12-16-3-4-16/h5-8,14,16-17,21H,3-4,9-13H2,1-2H3

説明

N-Nitroso-Betaxolol is an N-nitroso derivative of the secondary amine present in Betaxolol | which is a highly characterized reference material that meets stringent regulatory standards set for nitrosamine compounds | including those set by USP | EMA | JP | and BP. This nitroso standard is essential for a variety of applications | such as analytical method development | method validation (AMV) | and Quality Control (QC) | particularly in the context of Betaxolol production. It is suitable for use in both Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA). This nitrosamine standard helps establish detection limits | quantify impurity levels | and ensure trace nitroso impurities in pharmaceutical products remain within FDA and EMA safety limits.

見積もり依頼

「*」は必須フィールドを示します

このフィールドは入力チェック用です。変更しないでください。
Products quotation
Name
Url